Notable Labs (NTBL) Stock Analysis
NASDAQHealthcareBiotechnology
What Notable Labs does
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Key metrics
ETFs linked to NTBL
Broad-market and Healthcare sector ETFs an investor holding Notable Labs is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NTBL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NTBL in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Notable Labs?
- Notable Labs trades under the ticker NTBL on NASDAQ.
- Which exchange is NTBL listed on?
- NTBL is listed on NASDAQ.
- What sector does Notable Labs operate in?
- Notable Labs is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze NTBL in a portfolio?
- PortView shows NTBL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.